Published in
Springer, Diabetologia, 7(63), p. 1285-1298, 2020
DOI: 10.1007/s00125-020-05158-9
Links
Tools
The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial
Journal article published in 2020 by
Caroline T. B. Juel,
Asger Lund,
Jan H. Storkholm,
Jens F. Rehfeld,
Gerrit van Hall,
Bolette Hartmann,
Nicolai J. Wewer Albrechtsen,
Jens J. Holst,
Tina Vilsbøll,
Filip K. Knop 
,
Maria M. Andersen,
Carsten Palnæs Hansen
,
Maria M. Andersen,
Carsten Palnæs Hansen
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 